FDA NDC Directory · JSON-LD · Markdown

BETHKIS

NDC 10122-820 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nametobramycin
Labeler / ManufacturerChiesi USA, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA201820
Dosage form / routeSOLUTION · RESPIRATORY (INHALATION)
Active ingredientsTOBRAMYCIN (300 mg/4mL)
Marketing started20130415
Package count3

External sources

Source: openFDA. Public-domain (CC0).